This inventor holds 1 USPTO granted patent. Top assignee: Klinikum Der Universitat Munchen. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: Shan Guan - Innovator in Synthetic Compounds for Transfection
Introduction
Shan Guan is a notable inventor based in Munich, Germany. He has made significant contributions to the field of biotechnology, particularly in the development of synthetic compounds that enhance the efficiency of transfection in eukaryotic cells. His innovative work has the potential to advance various applications in genetic engineering and therapeutic interventions.
Latest Patents
Shan Guan holds a patent for a synthetic compound designed to improve the efficiency of transfection. The invention involves an amphiphilic block copolymer that includes a peptide residue with at least one targeting sequence and a nucleic acid binding sequence. This binding sequence consists of at least four consecutive positively charged amino acid residues at pH 7.4. The targeting sequence directs the compound to specific positions or structures within or on the surface of eukaryotic cells. Additionally, the synthetic compound features a hydrophobic moiety covalently linked to the peptide residue, which can include lipoic acid, lipoamide, tetradecyl, cholesteryl residues, or a peptide sequence with over 40% hydrophobic amino acid residues. This innovative approach enhances the transfection process, making it more efficient.
Career Highlights
Shan Guan is affiliated with Klinikum der Universität München, where he continues to work on groundbreaking research in the field of biotechnology. His expertise and innovative mindset have positioned him as a valuable contributor to the scientific community.
Collaborations
Shan collaborates with Joseph Rosenecker, a fellow researcher, to further explore the applications of his inventions and enhance their effectiveness in practical scenarios.
Conclusion
Shan Guan's work in developing synthetic compounds for transfection represents a significant advancement in biotechnology. His innovative approach and dedication to research continue to pave the way for future breakthroughs in genetic engineering and therapeutic applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile